Please use this identifier to cite or link to this item:
Ion channel determinants of cardiac hypertrophy and cardiomyopathy
|Buckley_Cadie_r.pdf||Version for non-UH users. Copying/Printing is not permitted||43.67 MB||Adobe PDF||View/Open|
|Buckley_Cadie_uh.pdf||Version for UH users||43.73 MB||Adobe PDF||View/Open|
|Title:||Ion channel determinants of cardiac hypertrophy and cardiomyopathy|
|Authors:||Buckley, Cadie L.|
|Issue Date:||Dec 2011|
|Publisher:||[Honolulu] : [University of Hawaii at Manoa], [December 2011]|
|Abstract:||The work presented in this dissertation address the role of two ion channels; TRPV1 and CRACM1, and the serine protease, Corin, in the progression of pressure-overload cardiac hypertrophy. Results show that the absence of TRPV1 in vivo is protective against cardiac hypertrophy under conditions of pressure overload (Chapter 2); however, in the absence of CRACM1 the pathology is exacerbated (Chapter 3). Further, mice lacking a gene disrupting Corin show an immediate and severe hypertrophic response (Chapter 4). Lastly, follow up studies with a TRPV1 blocker have proved effective in suppressing the progression of cardiac hypertrophy under conditions of pressure overload (Chapter 5). The results from this dissertation, for the first time, show that in vivo TRPV1 is a key player and therapeutic target in cardiac hypertrophy, CRACM1 plays an important protective role and Corin is necessary for the heart to compensate under conditions of pressure overload.|
|Description:||Ph.D. University of Hawaii at Manoa 2011.|
Includes bibliographical references.
|Appears in Collections:||Ph.D. - Molecular Biosciences and Bioengineering|
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.